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Abstract
Background: Germ cells arise from a small group of cells that express markers of pluripotency including OCT4.
In humans formation of gonadal compartments (cords in testis, nests in ovary) takes place during the 1st trimester
(6–8 weeks gestation). In the 2nd trimester germ cells can enter meiotic prophase in females whereas in males
this does not occur until puberty. We have used qRTPCR, Westerns and immunohistochemical profiling to
determine which of the germ cell subtypes in the human fetal gonads express OCT4, DAZL and VASA, as these
have been shown to play an essential role in germ cell maturation in mice.
Results: OCT4 mRNA and protein were detected in extracts from both 1st and 2nd trimester ovaries and
testes. In ovarian extracts a marked increase in expression of VASA and DAZL mRNA and protein occurred in
the 2nd trimester. In testicular extracts VASA mRNA and protein were low/undetectable in 1st trimester and
increased in the 2nd trimester whereas the total amount of DAZL did not seem to change. During the 1st
trimester, germ cells were OCT4 positive but did not express VASA. These results are in contrast to the situation
in mice where expression of Vasa is initiated in Oct4 positive primordial germ cells as they enter the gonadal ridge.
In the 2nd trimester germ cells with intense cytoplasmic staining for VASA were present in both sexes; these cells
were OCT4 negative. DAZL expression overlapped with both OCT4 and VASA and changed from the nuclear
to the cytoplasmic compartment as cells became OCT4-negative. In males, OCT4-positive and VASA-positive
subpopulations of germ cells coexisted within the same seminiferous cords but in the ovary there was a distinct
spatial distribution of cells with OCT4 expressed by smaller, peripherally located, germ cells whereas DAZL and
VASA were immunolocalised to larger (more mature) centrally located cells.
Conclusion: OCT4, DAZL and VASA are expressed by human fetal germ cells but their patterns of expression are
temporally and spatially distinct. In the 1st trimester OCT4 was detected in most germ cells. In the 2nd trimester
the onset of expression of VASA was associated with the formation of oocytes and spermatogonia both of which
were OCT-4 negative. Relocation of DAZL from nucleus to cytoplasm paralleled the down regulation of OCT4
and the onset of expression of VASA. These data reveal similarities between the expression of key regulatory
proteins within germ cells as they mature in male and female fetal human gonads suggesting that in the female
these maturational changes are not determined by entry into meiosis.
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Background
The ovaries and testes both develop from an identical
structure, the embryonic genital ridge [1]. Germ cells do
not originate from within the genital ridges but differenti-
ate from clusters of cells located in the extra-embryonic
proximal epiblast [2]. Primordial germ cells (PGC) prolif-
erate and migrate via the embryonal endoderm reaching
the gonadal ridges at about 5th week of pregnancy in the
human (reviewed in [3]). Within the genital ridge germ
cells have been shown to express the pluripotency markers
OCT4 (POU5F1, [4]) and NANOG [5] and human embry-
onic germ cell lines, capable of differentiating into a
number of cell lineages, have been established from early
gonadal tissue [6,7]. We have previously reported that
during the 1st trimester of pregnancy the germ cells (gono-
cytes) in the testicular cords all express OCT4 but that
only a subpopulation of germ cells remains OCT4 posi-
tive during the 2nd trimester [8]. In previous studies
OCT4 positive germ cells were detected in the cortical
region of human fetal ovaries recovered during the 2nd
trimester [9]; however expression of OCT4 has not been
investigated in the 1st trimester ovary.
Studies in knockout mice have identified a number of
genes the expression of which is critical for germ cell sur-
vival and functional maturation in both ovary and testis.
One such gene is Dazl, an RNA binding protein that is a
member of a conserved gene family members of which
include BOULE and DAZ [10,11]. A second example is
Mvh (mouse Vasa homologue) a gene that encodes an
RNA helicase which is specific to the germ cell lineage
[12]. In mice Dazl mRNA is first detectable in post-migra-
tory germ cells on e11.5 [11,13] and the protein has been
immunolocalised to the cytoplasm of fetal and adult germ
cells [14]. Targeted deletion of the Dazl gene results in
germ cell loss in both males and females [14]. In Dazl -/-
females germ cell loss occurred in fetal ovaries at the time
of meiotic entry and adult ovaries did not contain oocytes
[14,15]. In Dazl -/- males the pattern of germ cell loss is
variable and in some studies has been reported to occur
during fetal life [11] whilst in others it was associated with
spermatogonial differentiation [14,16] or entry to meiosis
[17].
VASA is a member of the DEAD box family of genes first
identified in Drosophila where it was shown to be essential
for female germ cell development [18]. In mice with tar-
geted deletions of Mvh ovarian function appeared normal
but males were infertile with demise of germ cells at the
zygotene stage of meiosis [19]. Mvh has been detected in
germ cells on e12.5 immediately after colonisation of the
gonad but not in migratory PGCs [12,19,20]. Information
on expression of VASA in human fetal gonads is limited
but protein was detected in OCT4 negative cells in a testis
at 21 weeks gestation [21]. First trimester ovaries have not
been examined but in the 2nd trimester VASA has been
localised to oocytes within primordial follicles [9].
In the present paper we have extended our studies on the
germ cell subpopulations within the human fetal ovaries
and testes to determine when and where DAZL and VASA
proteins are expressed and have performed co-staining for
OCT4 as this is commonly used to delineate the germ
'stem cell' population [8,22,23]. These studies have
revealed a dynamic and overlapping pattern in the expres-
sion of these germ cell markers, revealed that nuclear
localisation of DAZL parallels the onset of VASA expres-
sion, and highlighted similarities in the development of
male and female germ cell lineages.
Results
Expression of mRNAs for OCT4, DAZL and VASA in first 
and second trimester gonads
In ovaries OCT4 mRNA was detected in both the 1st and
2nd trimester samples with a slight, but non-significant
decrease in the older samples (Figure 1A). In contrast the
amount of mRNA for DAZL and VASA was very low in 1st
trimester ovaries but was markedly increased in the 2nd
trimester DAZL 20 fold and VASA 50 fold (both P < 0.001,
Figure 1B,C),. Analysis of individual ovarian samples
showed a very high correlation between expression of
DAZL and VASA mRNAs (Spearman correlation coeffi-
cient 0.74, P < 0.0001). In the testis, OCT4 and DAZL
mRNAs were detectable in both 1st and 2nd trimester
with no significant difference between ages (Figure 1A, B).
Expression of VASA mRNA in the testis was low/barely
detectable in the 1st trimester and showed a significant
increase in the 2nd trimester (p = 0.001) although this
was less marked than that seen in ovarian samples (Figure
1C).
Expression of mRNAs for OCT4, DAZL and VASA in 1st and  2nd trimester ovary and testis Figure 1
Expression of mRNAs for OCT4, DAZL and VASA in 1st and 
2nd trimester ovary and testis. Open columns, 1st trimester, 
shaded columns 2nd trimester. Concentrations of mRNA are 
all relative to that of GAPD in the same samples. * P < 0.001 
vs 1st trimester. Mean ± sem, n = 5–18 per group.BMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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Western analysis of total protein levels
In both ovaries and testes VASA protein was not detected
in samples from the 1st trimester (Figure 2A, B) but an
increase in the amount of VASA was noted during the 2nd
trimester (14–19 weeks) which was particularly striking in
the ovarian samples (Figure 1A, B).
DAZL protein was detected in both 1st and 2nd trimester
testes (Figure 2D) but only in the 2nd trimester ovaries
(Figure 2C). OCT4 was detected in extracts from ovaries
and testes obtained during both 1st and 2nd trimesters
(Figure 2E, F).
Immunolocalisation of OCT4, DAZL and VASA revealed 
differential patterns of expression in both ovary and testis
Immunoexpression of OCT4, DAZL and VASA was germ
cell specific in all samples. OCT4 positive germ nuclei
were detected in both 1st and 2nd trimester ovaries (Fig-
ure 3a, b) and testes (Figure 3c, d). In both sexes immuno-
positive cells were distributed throughout the organ
during the 1st trimester. In 2nd trimester testes OCT4 pos-
itive germ cells were detected in all seminiferous cords
whereas in the ovary expression of OCT4 positive nuclei
was largely confined to the peripheral cortex (Figure 3b).
DAZL was immunolocalised to the nuclei of germ cells in
1st trimester gonads in both sexes. In 2nd trimester ova-
ries DAZL immunostaining was largely cytoplasmic and
appeared to be most prominent in groups of cells (N in
Figure 3f), whereas in the testes germ cells with nuclear or
cytoplasmic staining were detected throughout the organ
(Figure 3h). No VASA immunopositive cells were detected
in 1st trimester gonads from either sex (not shown). In the
2nd trimester ovaries VASA staining was cytoplasmic and
more intense in germ cells less peripherally located than
those expressing OCT4 (Figure 3i, j); in testes VASA posi-
tive cells were distributed throughout the organ.
Co-localisation of OCT4 and DAZL
In 1st trimester ovaries and testes (Figure 4a and 4b,
respectively) OCT4 and DAZL were co-expressed in germ
cell nuclei. In the 2nd trimester ovaries (Figure 4c) germ
cells containing intense positive nuclear immunoreactiv-
ity for OCT4 were immunonegative for DAZL; in a few
cells with low levels of OCT4 (Figure 4c arrowheads) a
small amount of cytoplasmic DAZL was detected. In con-
trast, intense immunoexpression of DAZL was detected in
the cytoplasm of less peripherally located groups of oogo-
nia (arrow). However in 2nd trimester testes DAZL immu-
noexpression was heterogeneous with nuclear (Figure 4d)
as well as cytoplasmic staining in OCT4 positive cells as
well as cytoplasmic expression in cells that were OCT4
negative (Figure 4e, arrow).
Differential expression of OCT4 and VASA
In 1st trimester ovaries and testes all germ cells contained
OCT4 positive nuclei but were immunonegative for VASA
(not shown). In the 2nd trimester, OCT4 positive germ
cells were located at the periphery of the ovary whereas
the most intense immunoexpression of VASA was
detected in the cytoplasm of OCT4 negative germ cells
(oogonia) located in nests (Figure 5a, labelled N) in the
central region. Expression of OCT4 and VASA was almost
mutually exclusive although some cells in a transition
zone between the peripheral cells that contained intense
OCT4 staining and the nests of VASA positive cells (e.g.
arrowhead in panel 5a) did appear to have low levels of
VASA in their cytoplasm and some nuclear OCT4. In the
testes a the majority of germ cells (gonocytes, [8]) con-
taining intense immunoexpression of OCT4 were located
in the central portion of the seminiferous cords and these
cells were VASA negative (Figure 5b). As in the ovary germ
cells that contained intense cytoplasmic staining for VASA
were OCT4 negative, these were often found in groups at
the periphery of the cords. Nuclear expression of VASA
was detected in some germ cells (Figure 5b, asterisks). As
in the ovary rare germ cells containing very low levels of
cytoplasmic VASA as well as low intensity staining for
OCT4 were observed (Figure 5b arrowheads).
Western analysis of 1st and 2nd trimester ovaries and testes Figure 2
Western analysis of 1st and 2nd trimester ovaries 
and testes. In both ovarian (A) and testicular (B) samples 
VASA (76 Kd) was not detectable in the 1st trimester sam-
ples but was present in those from the 2nd trimester. DAZL 
(33 Kd) was low/undetectable in 1st trimester ovaries (C) 
whereas it was detectable in ovarian samples from 2nd tri-
mester and testicular samples from both 1st and 2nd trimes-
ter (D). OCT4 (42 Kd) was present in both ovaries (E) and 
testes (F) during both the 1st and 2nd trimester. The loading 
control in all cases was β-tubulin (51 Kd).BMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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Differential and overlapping expression of DAZL and VASA
The above data suggested that expression of DAZL and
VASA was similar but not identical, in both ovary and tes-
tis. This was directly investigated by dual immunohisto-
chemistry for DAZL and VASA in the 2nd trimester (Figure
6). This identified the presence of three populations of
germ cells in both ovary and testis based on their patterns
of expression of DAZL and VASA. Firstly a rare population
of cells that expressed nuclear DAZL alone, secondly cells
which co-expressed both proteins (population 2), and
thirdly cells which were VASA positive/DAZL negative
(population 3) which were the most prevalent. Although
only few cells in population 2 were detected in testes these
germ cells were found as distinct groups within the ovary
(Figure 6b). Oocytes within primordial follicles expressed
VASA with low/absent expression of DAZL.
Immunoexpression of OCT4, DAZL and VASA Figure 3
Immunoexpression of OCT4, DAZL and VASA. OCT4 positive germ cell nuclei were detectable in both the 1st and 2nd 
trimester ovaries (a, 62 d; b, 16 wk) and testes (c, 64 d; d, 16 wk). DAZL positive germ cells were rare in the 1st trimester (e, 
ovary 61 d; g, testis 64 d) but groups of cells ('nests', labelled N) with cytoplasmic staining were present in the 2nd trimester 
ovaries (f, 20 wk). During the 2nd trimester VASA protein was detected in the cytoplasm of female germ cells (i, 14 wk; j, 18 
wk) throughout the ovary with the exception of the sub-epithelial layer. In the testes (k, 15 wk; l, 16 wk) VASA-positive germ 
cells were found in all cords.BMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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In the ovarian samples the pattern of expression was fur-
ther investigated by measuring germ cell diameter at 3 rep-
resentative gestations (14, 16 and 19 weeks) as our
previous studies have established that cell diameter pro-
vides an indication of the maturational status of the
human fetal female germ cell [23]. This demonstrated that
DAZL-predominant germ cells were smaller than germ
cells showing marked expression of both proteins, which
were in turn smaller than germ cells expressing VASA
alone (Figure 7). These differences were significant at each
gestational age examined (P < 0.001). This analysis also
demonstrated that germ cells expressing only DAZL
showed an increase in diameter from 10.6 ± 0.2 to 11.8 ±
0.3 μm (P < 0.01) between 14 and 19 weeks gestation, the
cells found in groups that expressed both DAZL and VASA
increased from 12.6 ± 0.3 to 14.0 ± 0.4 μm (P = 0.001)
and those predominantly expressing VASA from 14.0 ±
0.3 to 17.8 ± 0.3 μm (P < 0.001).
Discussion
Germ cells within the male and female gonads develop
from an apparently homogeneous bi-potential popula-
tion of PGC. In both male and female human fetal gonads
germ cells initially proliferate but thereafter their fates
diverge with female germ cells entering meiotic prophase
as early as 11 weeks gestation (9 weeks post conception;
[24]) whereas meiotic entry is does not occur until
puberty in males. In rodents male germ cells removed
from the testicular environment and placed in vitro can
spontaneously enter meiosis emphasising the common
developmental potential of the germ cells in the two sexes
and the critical role played by the testicular environment
in modifying germ cell fate [25,26].
In the current study we have used OCT4 immunohisto-
chemistry to identify the subpopulation of putative 'germ
stem' cells in human fetal testes and ovaries. Studies from
our own laboratory [8] have already established that
expression of OCT4 is restricted to the gonocyte popula-
tion of human testicular germ cells whilst others [27] have
reported that this protein is localised to oogonia in the
ovary. Expression of DAZL and VASA was compared to
OCT4 as studies in knockout mice have reported that both
Co-localisation of OCT4 and VASA in 16 week ovary and  testes Figure 5
Co-localisation of OCT4 and VASA in 16 week ovary 
and testes. Panel a, ovary, cells with intense immunoposi-
tive staining for OCT4 are found at the periphery of the 
organ (red nuclei), VASA was detected in the cytoplasm and 
was most intense in cells located in nests (N) closer to the 
centre of the ovary. An intermediate population of cells with 
low intensity nuclear staining for OCT4 and low intensity 
staining for VASA (arrowheads) was also present. Panel b, 
testis, OCT4 positive and VASA positive germ cells were 
found within the same seminiferous cords; germ cells with 
intense nuclear OCT4 expression (red nuclei) were VASA 
negative and those with intense cytoplasmic expression of 
VASA (e.g. arrowed in inset panel b) were OCT 4 negative. 
Two other populations of male germ cells were identified, a 
population with low intensity immunoexpression of OCT4 
which also had low intensity staining for VASA (arrowheads) 
and cells with nuclear VASA expression (asterisks) which 
were typically found in pairs.
Co-localisation of OCT4 and DAZL Figure 4
Co-localisation of OCT4 and DAZL. In 1st trimester 
ovaries (a, 61 d) and testes (b, 64 d) OCT4 (green) and 
DAZL (red) were co-localised to germ cell nuclei. In ovaries 
from the 2nd trimester (c, 14 wk) DAZL protein was almost 
exclusively cytoplasmic and was largely localised to OCT4 
negative groups of cells (arrow); a few OCT4 positive cells 
had a low level of DAZL immunoexpression in their cyto-
plasm (arrowheads). Testes, panel b, 64 d; panel d, 16 wk; 
panel e, 19 wk gestation. In 2nd trimester testes (d, 16 wk; e, 
19 wk) DAZL was still expressed in the nuclei of some 
OCT4 positive germ cells but this pattern of expression was 
variable with DAZL protein present in the cytoplasm of 
OCT4 positive and OCT4 negative (arrow panel e) cells.BMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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genes are essential for germ cell maturation in that species
[14,19]. Analysis of ovarian extracts revealed a striking
increase in the total amount of both DAZL and VASA
mRNA and protein in the ovary as development pro-
gressed into the 2nd trimester. A similar trend in expres-
sion was noted in the testes but was less striking.
Expression of OCT4 was maintained in both ovary and
testis at all gestational ages examined consistent with per-
sistence of a putative germ 'stem cell' population for many
months in the human gonads although the extent to
which these cells can acquire/maintain pluripotency in
vitro remains unresolved (reviewed in [28]). In the 2nd tri-
mester testis all seminiferous cords contained a mixture of
OCT4 positive and OCT4 negative germ cells a situation
which is different to that in rodents where the expression
of OCT4 is down regulated synchronously in all germ cells
within the cords before birth [29,30]. In the human fetal
ovary expression of OCT4 protein was restricted to oogo-
nia in the peripheral zone of the organ, in agreement with
the observations of Stoop et al.[9]. In mice expression of
Oct4 mRNA is extinguished in a rostro-caudal wave coin-
cident with meiotic entry of germ cells [31].
Co-incident and overlapping patterns of expression of
these germ cell specific proteins were revealed by fluores-
cent co-immunolocalisation on fixed specimens from a
range of gestational ages. Previous studies have immu-
nolocalised DAZL in a small number of samples recovered
in the 2nd trimester [32-34] but we believe this is the first
study to document expression in 1st trimester samples
and to compare expression with that of OCT4 and VASA.
In the 1st trimester, DAZL was detected in the nuclear
compartment in OCT4 positive germ cells in both sexes.
In a previous study we immunolocalised DAZL to the
nuclei of male germ cells in a single sample at 17 weeks
gestation and in the cytoplasm of female germ cells at 15
weeks [33]. Other studies have claimed that DAZL is
present in both the cytoplasm and nucleus of male germ
cells at 20–21 weeks [34]. We have extended these obser-
vations and demonstrated that DAZL is localised to the
nuclear compartment in OCT4 positive cells (gonocytes
and oogonia). In the ovaries localisation of DAZL to the
cytoplasmic compartment appeared to be transient occur-
ring as OCT4 expression but thereafter the amount of pro-
tein declined and was low in the largest ovarian germ
cells, i.e. those that had formed into primordial follicles
and those approaching that stage. This was evident when
a morphometric analysis was performed showing that the
germ cells immunopositive for DAZL alone were smaller
than those containing both DAZL and VASA, which were
in turn smaller than those only immunopositive for
VASA.
Two studies on human populations have provided pre-
liminary evidence that expression of DAZL is important
for normal functioning of the human germ line. The first
study reported a strong association between several com-
Ovarian germ cell diameter for cells expressing DAZL, VASA  or both at 14, 16 and 19 weeks gestation Figure 7
Ovarian germ cell diameter for cells expressing DAZL, VASA 
or both at 14, 16 and 19 weeks gestation. There were signifi-
cant increases in diameter with gestation for each group (p = 
0.001 for DAZL and VASA separately, p = 0.01 for cells 
expressing both). There were also significant differences (P < 
0.01) between the 3 classifications of germ cell at each gesta-
tion. Mean ± sem, n = 20–120 per group.
Co-localisation of DAZL and VASA in 2nd trimester ovary  and testes Figure 6
Co-localisation of DAZL and VASA in 2nd trimester 
ovary and testes. In the 2nd trimester (ovary, a, 17 wk; c, 
14 wk; testes b, 15 wk; d, 16 wk) three populations of germ 
cells were identified based on their patterns of expression of 
DAZL (red) and VASA (green). 1stly a rare population of 
cells which had nuclear DAZL (arrows), 2ndly cells which co-
expressed both proteins (population 2) and thirdly the most 
prevalent group which were VASA positive/DAZL negative 
(population 3). Although few cells in population 2 were 
detected in testes these germ cells were found as distinct 
groups within the ovary (see panel c).BMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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mon single nucleotide polymorphisms (SNPs) and age at
menopause in a sample population of 324 women [35].
In a second study a patient with premature ovarian failure
at age 34 was found to contain a homozygous mutation
of DAZL (Arg to Gly at 115) in a region of the protein crit-
ical for RNA binding [35]. The situation in men is compli-
cated by the presence of multiple copies of the closely
related  DAZ  gene on the Y chromosome, deletions of
which have been frequently documented as a cause of
male infertility [36]. However a patient with a
homozygous mutation in DAZL  (Asn 10 Cys) was
reported to be azoospermic [35].
The marked increase in expression of VASA between 9 and
14 weeks gestation suggested to us that this was coinci-
dent with the entry of female germ cells into meiosis.
However increases in both protein and mRNA were also
demonstrated in male germ cells suggesting that the onset
of expression of VASA was associated the maturation of
the gonocytes into prespermatogonia rather than meiotic
entry per se. In the ovary VASA was detected in the cyto-
plasm of in slightly larger, more mature germ cells than
DAZL, and was also present in oocytes within primordial
follicles. Previous studies that have detected expression of
VASA in cytoplasm of germ cells within the fetal ovary and
testes at 17 weeks gestation [9,21,37]. Co-staining of sec-
tions with OCT4 and VASA has extended these findings by
demonstrating that VASA protein is not expressed in
gonocytes or oogonia in the 1st trimester and provides a
useful method for identifying the different populations of
germ cells present within the 2nd trimester gonads.
Examination of the 3' UTR of the Mvh mRNA has revealed
a number of putative Dazl-binding sites that are con-
served between human, rat and mouse [38]. Our data pro-
vide some additional support for a role for DAZL in
initiating expression of VASA although further studies are
required preferably using isolated human germ cells.
DAZL has also been implicated in the regulation of other
conserved germ-cell RNA-binding proteins including
PUM2 [39], the human homolog of Pumilio  that is
required for maintenance of germ line stem cells in Dro-
sophila and Caenorhabditis elegans.
Conclusion
By documenting the differential and partially overlapping
patterns of expression of OCT4, DAZL and VASA proteins
in the human fetal ovary and testis we have gained new
insight into parallels in the maturation of germ cells in
these two organs. Our findings clearly demonstrate
changes in overall germ cell maturation with increasing
gestation, and indicate a switch from OCT4 expression in
the less mature germ cells (gonocytes, peripheral oogo-
nia) to VASA expression in the more mature germ cells
(prespermatogonia, oogonia in nests, oocytes). In testicu-
lar samples germ cells at different stages of maturation co-
exist within the same seminiferous cords. Both male and
female germ cells showed a similar pattern of change with
development, despite the onset of meiosis in the female
but not in the male, suggesting that although increases in
expression of DAZL and VASA in the ovary may be related
to meiotic entry there are underlying developmental pat-
terns common to both sexes.
Methods
Tissue recovery and processing
Human fetal gonads were obtained following termination
of pregnancy during the first (61–64 days gestation, n =
11) and 2nd trimesters (14 to 19 weeks gestation, n = 29).
Women gave written consent according to national guide-
lines [40] and the study was approved by the Lothian Eth-
ics Committee. Termination of pregnancy was induced by
treatment with mifepristone (200 mg, orally), followed by
misoprostol (Pharmacia, Surrey UK; 200 mg every 3 h, per
vaginam). None of the terminations was for reasons of
fetal abnormality, and all fetuses used in this study
appeared morphologically normal. Gestational age was
determined by ultrasound examination before termina-
tion and was confirmed by subsequent direct measure-
ment of foot length in 2nd trimester samples. The sex of
the 1st trimester fetal gonads was determined by PCR for
the SRY gene as detailed in [8]. Testes and ovaries were
dissected carefully from the fetal abdominal cavity and
either snap frozen and stored at -70°C prior to extraction
of total protein or RNA, or fixed in Bouins fluid for 2–3 h,
stored in 70% ethanol and processed into paraffin wax
using standard methods.
RNA Extraction and RT PCR
Total RNA was extracted from fetal gonads using the RNe-
asy Mini Kit (Qiagen, UK) for mid trimester gonads and
the RNeasy Micro Kit for 1st trimester gonads (with on-
column DNase digestion Qiagen, UK) The RNA was
primed for reverse transcription with oligo(dT) primer
(Applied Biosystems, UK) at 65°C for 10 min. The entire
reaction was added to a total volume of 38 μl containing
dNTP to 1 mmol/l, dithiothreitol (DTT) to 10 mmol/l, 1×
Expand Reverse Transcriptase (RT) buffer and 120 IU
RNasin ribonuclease inhibitor (Promega Ltd, UK). One
half (19 μl) of this reaction was added to 1 μl water (RT
negative reaction) to act as a negative control to confirm
the effiency of the DNase treatment. Fifty IU of Expand
Reverse Transcriptase (Roche Diagnostics Ltd) was added
to the remaining 19 μl (RT positive reaction) and both
reactions were incubated for 1 h at 42°C. Reactions were
stored at -20°C until required.
Real-time quantitative PCR
Quantitative real-time RT-PCR was performed using the
Lightcycler (Roche Diagnostics Ltd) as described previ-BMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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ously [41]. Reverse-transcribed RNA samples were diluted
in water as indicated below. One microlitre of diluted
first-strand cDNA was added to a final volume of 10 μl
containing 50 μg/ml non-acetylated bovine serum albu-
min and 0.5 μmol/l each of forward and reverse primer in
1× Platinum®SYBR Green qPCR SuperMix-UDG (Invitro-
gen. Paisley, UK). Amplification was continued for 45
cycles with signal acquisition at 84°C after each round of
extension. Following amplification, continuous melt
curve analysis was performed to ensure product accuracy
and samples were analysed by agarose gel electrophoresis
(data not shown) to confirm product size. Primer
sequences are given in Table 1, Standard curves for GAPD,
OCT4, DAZL and VASA were derived by making a series of
dilutions (1 in 5 to 1 in 10000) of first-strand cDNA from
a mid trimester ovary. The number of cycles needed to
yield a fluorescent signal above background (the cross-
over point, Cp) at each dilution was plotted against the
log of relative concentration using LightCycler Software
(Molecular Dynamics Ltd, UK). The dilutions yielded a
straight line for each product, confirming that Cp is a
good indicator of target concentration across at least 2
orders of magnitude. The slopes of these curves are a
measure of the efficiency of the PCR, which gave an
amplification rate of 1.8-fold/cycle for GAPD and DAZL,
and 1.7-fold/cycle for OCT4 and VASA. All gene amplifi-
cation reactions were performed in triplicate. Calculations
of mRNA concentration were made relative to GAPD.
Western blot analysis
Fetal gonads were homogenised in 1× RIPA buffer con-
taining: 25 mM Tris, 1% Triton, 0.05% sodium deoxycho-
late, 0.1% SDS and 150 mM NaCl. Total protein was
measured using the Protein Assay DC Kit from Bio-Rad
(Hemel Hempstead, Herts, UK). Samples were denatured
in 1× reduced sample buffer containing: 625 mM Tris (pH
6.8), 5% glycerol, 2% SDS, 0.0025% bromophenol Blue,
2.5% β-mercaptoethanol and 5 μg of total protein was
loaded onto individual wells in a SDS-PAGE gel made
with 10% (w/v) acrylamide; samples of pre-stained pro-
tein size markers were run on each gel (SeeBlue plus 2
prestained standard, Invitrogen, UK). Following separa-
tion of proteins they were transferred onto PVDF Immo-
bilon-Fl membranes (Millipore UK Ltd, Watford, Herts);
non-specific binding sites were blocked by incubating
membranes in Odyssey blocking buffer (LI-COR, Lincoln,
Nebraska, USA). All membranes were incubated with pri-
mary antibodies diluted in Odyssey blocking buffer over-
night at 4°C. Proteins were detected using rabbit-anti-
VASA (DDX4MVH, Abcam, Cambridge UK) diluted 1 in
500 together with mouse anti-β tubulin (cat no. T-4026,
Sigma) diluted 1 in 300, mouse anti-DAZL (gift from Pro-
fessor Howard Cook, MRC Human Genetics Unit, Edin-
burgh) diluted 1 in 500, with rabbit anti-β-tubulin (cat
no. sc-9104, Santa Cruz) diluted 1 in 1000, or with goat
anti-OCT4 (Santa Cruz) together with rabbit anti-β-tubu-
lin (Santa Cruz) diluted 1 in 1000. Membranes were
washed in PBS containing 0.1% Tween and bound anti-
bodies were detected using fluorescently labelled second-
ary antibodies: goat anti-rabbit 680 (Invitrogen, Paisley,
UK) and goat anti-mouse 800 (Invitrogen, Paisley, UK)
for VASA and β-tubulin respectively; goat anti-mouse 680
(Invitrogen, Paisley, UK) and goat anti-rabbit 800 (Rock-
land, USA) for DAZL plus β-tubulin; while OCT4 and β-
tubulin, were detected using donkey anti-goat 680 (Invit-
rogen Paisley, UK) and goat anti-rabbit 800 (Rockland,
USA). Secondary antibodies were all diluted 1 in 10000 in
Odyssey blocking buffer and incubated for 1 h at room
temperature; bound fluorescent secondary antibodies
were visualised using a LI-COR-Odyssey Infrared Imager
(LI-COR Biosciences, Lincoln Nebraska).
Immunofluorescence co-localisation
Immunolocalisation was carried out using standard meth-
ods [8]. Briefly, 5 μm sections were mounted onto electro-
statically charged microscope slides (VWR, Poole, UK),
dried overnight, then dewaxed and rehydrated using con-
ventional methods. Heat-induced antigen retrieval was
performed by placing slides in a pressure cooker in 0.01 M
citrate pH 6 for 5 min on full power with 20 min standing
prior to cooling. Slides were transferred into Tris-buffered
saline (TBS; 0.05 M Tris, 0.85% NaCl (pH 7.6)) for 5 min
and blocked in TBS with 20% normal serum (Diagnostics
Scotland, Carluke, UK), 5% BSA and avidin (0.01 M, 15
min) then biotin (0.001 M, 15 min; both from Vector Lab-
oratories, Peterborough, UK) with washes in TBS in
Table 1: Primers used for quantitative PCR
Gene Sequence Accession No. Product Size
hGAPDF GACATCAAGAAGGTGGTGAAGC
hGAPDR GTCCACCACCCTGTTGCTGTAG NM_002046 212 bp
hDDX4MVH F AAGAGAGGCGGCTATCGAGATGGA
hDDX4MVH R CGTTCACTTCCACTGCCACTTCTG NM_024415 238 bp
hOCT4F ACATCAAAGCTCTGCAGAAAGAAC
hOCT4R CTGAATACCTTCCCAAATAGAACCC NM_002701 126 bp
hDAZLF GAAGGCAAAATCATGCCAAACAC
hDAZLR CTTCTGCACATCCACGTCATTA NM_ 001351 186 bpBMC Developmental Biology 2007, 7:136 http://www.biomedcentral.com/1471-213X/7/136
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between. Primary antibodies and detection are listed in
Table 2. All primary antibodies were incubated on sec-
tions overnight at 4°C. Biotinylated secondary antibodies
were incubated for 30 min at room temperature. Peroxi-
dase-labelled and direct conjugate antibodies were incu-
bated for 1 h at room temperature. Tyramide was left for
10 min and all slides were counterstained with DAPI
(Sigma, cat no D9542) diluted 1/2000 in PBS. Mounted
slides were visualised using a laser scanning confocal
microscope (Zeiss).
Statistical analysis
Three representative non-adjacent tissue sections from
ovaries at gestational ages 14, 16 and 19 weeks immunos-
tained for DAZL and VASA were analysed. The cell diame-
ter of all immunopositive germ cells on each section was
calculated as the average of two orthogonal measurements
and classified as expressing DAZL, VASA or both. Data
were analysed by analysis of variance with Tukey-Kramer
post hoc testing.
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